Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JD.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.441NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.509NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.293NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.225NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.637NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.39 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.26 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.103 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MD.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LP.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.65.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDVNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KS.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MK.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.7.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.42.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.48.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.64NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LR.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KR.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used